Danielle Campbell
Human Resources Officer at ATYR PHARMA, INC.
Danielle Campbell active positions
Companies | Position | Start | End |
---|---|---|---|
ATYR PHARMA, INC. | Human Resources Officer | 24/12/2021 | - |
Career history of Danielle Campbell
Former positions of Danielle Campbell
Companies | Position | Start | End |
---|---|---|---|
POSEIDA THERAPEUTICS, INC. | Human Resources Officer | 01/01/2016 | 01/01/2019 |
Corporate Officer/Principal | 01/01/2019 | 01/01/2021 | |
ATYR PHARMA, INC. | Human Resources Officer | 01/11/2015 | 01/06/2016 |
Celladon Corp.
Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA. | Human Resources Officer | 01/09/2014 | 01/11/2015 |
Cytori Therapeutics, Inc.
Cytori Therapeutics, Inc. BiotechnologyHealth Technology Cytori Therapeutics, Inc. develops treatments and devices for cell therapy. The private company is based in San Diego, CA. | Human Resources Officer | 01/04/2008 | 01/09/2014 |
Training of Danielle Campbell
University of California, Irvine | Undergraduate Degree |
Statistics
International
United States | 6 |
Operational
Human Resources Officer | 5 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
ATYR PHARMA, INC. | Health Technology |
POSEIDA THERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
Celladon Corp.
Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA. | Health Technology |
Cytori Therapeutics, Inc.
Cytori Therapeutics, Inc. BiotechnologyHealth Technology Cytori Therapeutics, Inc. develops treatments and devices for cell therapy. The private company is based in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Danielle Campbell
- Experience